1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
10
Carnegie Strategifond D
Fee
1.50%
ISIN
SE0013525276
Holdings
26
We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with Carnegie Strategifond D, we have 36 holdings where Investor is the largest holding (6.69), followed by Volvo (4.48) and Essity (4.45).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Carnegie Strategifond D.
| UBS Lux Equity Fund Biotech USD | Carnegie Strategifond D |
|---|---|
|
10.04 % |
 6.69 % |
|
9.35 % |
4.48 % |
|
9.21 % |
4.45 % |
|
6.96 % |
4.08 % |
 5.53 % |
3.34 % |
|
4.66 % |
2.82 % |
|
4.3 % |
2.8 % |
|
4.13 % |
2.56 % |
|
3.75 % |
2.44 % |
|
3.37 % |
2.39 % |
| - |
2.14 % |
| - |
 2.04 % |
| - |
1.89 % |
| - |
1.83 % |
| - |
1.83 % |
| - |
1.79 % |
| - |
1.78 % |
| - |
1.75 % |
| - |
1.65 % |
| - |
 1.62 % |
| - |
1.55 % |
| - |
1.28 % |
| - |
1.19 % |
| - |
1.15 % |
| - |
1.09 % |
| - |
1.08 % |
The list of fund holdings was last updated on June 5, 2025.
